Indefinite Delivery Contract SPE2D019D0002

Award Date 12/1/18
Last Date to Order 11/30/28
Federal Agency
Medical Supply Chain
Ultimate Awardee
Cardinal Health, Inc.
Federal Contract Vehicle
Pricing Type
Fixed Price with Economic Price Adjustment
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
The Indefinite Delivery Contract (IDC) SPE2DM20D9103, awarded by the Defense Logistics Agency (DLA) to Cardinal Health 200, LLC, a subsidiary of Cardinal Health, Inc., aims to provide a wide range of medical and pharmaceutical products to support military treatment facilities and DoD customers in DLA Region 1. The single-award IDC, with a ceiling value of $4,999,999, runs through August 2027 and allows for the rapid procurement of surgical dressings, drugs, biologicals, and other medical...
This indefinite delivery contract (IDC) was awarded by the Defense Logistics Agency (DLA) to Cardinal Health 200, LLC, a subsidiary of Cardinal Health, Inc. The single-award IDC has a ceiling value of $4,999,999 and a period of performance through June 7, 2027. It is intended to provide a flexible procurement mechanism for the DLA and other Department of Defense (DoD) customers to rapidly acquire a wide range of medical supplies under Federal Supply Group 46 and Federal Supply Class 6515....
This Indefinite Delivery Contract (IDC) was awarded by the Defense Logistics Agency (DLA) to Cardinal Health, Inc., a global healthcare services and products company, for the Pharmaceutical Prime Vendor Fleet program. The contract, valued at $4,999,999.00, is for the provision of a comprehensive range of pharmaceutical and medical products, including prescription medications, over-the-counter drugs, vaccines, and medical consumables, to support military treatment facilities and deployed troops...
The Indefinite Delivery Contract (IDC) SPE2DV17D2042 was awarded to Cardinal Health 200, LLC, a subsidiary of Cardinal Health, Inc., by the Defense Logistics Agency (DLA). This single-award IDC has a ceiling value of $4,999,999.00 and a period of performance through June 7, 2027. The contract covers a wide range of medical and pharmaceutical products under Federal Supply Group 46 and Federal Supply Class 6515, supporting military treatment facilities and other Department of Defense (DoD)...
The Indefinite Delivery Contract (IDC) SPE2DV17D8009 was awarded by the Defense Logistics Agency (DLA) to Cardinal Health 200, LLC, a subsidiary of Cardinal Health, Inc. The single-award IDC has a ceiling value of $4,999,999.00 and a period of performance through June 7, 2027. This contract vehicle enables the DLA to issue multiple delivery orders for a wide range of medical and pharmaceutical products under Federal Supply Group 46 and Federal Supply Class 6515, primarily supporting military...
The Indefinite Delivery Contract (IDC) SPE2DV17D9262 was awarded to Cardinal Health 200, LLC, a subsidiary of Cardinal Health, Inc., by the Defense Logistics Agency (DLA). This single-award IDC has a ceiling value of $4,999,999.00 and runs through June 7, 2027. The contract enables the procurement of a wide range of medical supplies under Federal Supply Group 46 and Federal Supply Class 6515, including surgical dressings, drugs, biologicals, medical consumables, and specialized medical...
The federal contract IDV is a Federal Supply Schedule contract awarded by the Department of Veterans Affairs (VA) National Acquisition Center to The Harvard Drug Group, L.L.C., a subsidiary of Cardinal Health, Inc. The contract is for the provision of 65 I B, DRUGS, PHARMACEUTICALS, & HEMATOLOGY RELATED PRODUCTS, with a total ceiling value of $420,103,330.00 and a period of performance through May 31, 2030. The Harvard Drug Group, L.L.C. is a for-profit, Native Hawaiian Organization-owned...
The Indefinite Delivery Contract (IDC) SPE2DV17D8258 was awarded by the Defense Logistics Agency (DLA) to Cardinal Health 200, LLC, a subsidiary of Cardinal Health, Inc. The single-award IDC has a ceiling value of $4,999,999.00 and a period of performance through June 7, 2027. This IDC enables the rapid procurement of a wide range of medical and pharmaceutical products under Federal Supply Group 46 and Federal Supply Class 6515, primarily supporting military treatment facilities and other...
The federal Indefinite Delivery Contract (IDC) SPE2DV17D9244 was awarded by the Defense Logistics Agency (DLA) to Cardinal Health 200, LLC, a subsidiary of Cardinal Health, Inc. This single-award IDC has a ceiling value of $4,999,999.00 and a period of performance through June 7, 2027. The contract covers the procurement of a broad range of medical supplies and pharmaceutical products under Federal Supply Group 46 and Federal Supply Class 6515, including surgical dressings, drugs, biologicals,...
The Indefinite Delivery Contract (IDC) SPE2DV17D8040 was awarded by the Defense Logistics Agency (DLA) to Cardinal Health 200, LLC, a subsidiary of Cardinal Health, Inc. This single-award IDC has a ceiling value of $4,999,999 and runs through June 2027. The contract covers the procurement of a wide range of medical and pharmaceutical products under Federal Supply Group 46 and Federal Supply Class 6515, primarily supporting military treatment facilities and other Department of Defense...
  • SPE2D019D0002
    Indefinite Delivery Contract
  • 3K
    Federal Contract Awards

The Indefinite Delivery Contract (IDC) SPE2D019D0002 was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to The Harvard Drug Group, L.L.C., a subsidiary of Cardinal Health, Inc. The contract has a total ceiling value of $9,173,347.42 and a period of performance from December 1, 2018, to November 30, 2028.

Under this IDC, The Harvard Drug Group, L.L.C. is delivering a wide range of pharmaceutical and medical supply products to federal agencies, primarily the Department of Defense and Department of Veterans Affairs. The task orders issued to date include over-the-counter medications, medical supplies, and prescription-related items such as sodium chloride solutions, acetaminophen, prenatal tablets, loratadine, mucus relief tablets, and various topical creams and lotions. The delivery orders are predominantly firm fixed-price contracts with relatively low ceiling values, indicating a high-volume, low-cost supply strategy to support military and federal healthcare systems. The Harvard Drug Group, L.L.C.'s status as a for-profit, Native Hawaiian Organization-owned limited liability company allows it to compete for these unrestricted federal contract opportunities.

Generated 7/2/25, 10:34 PM